Publication Name	World Journal of Clinical Cases
Manuscript ID	88419
Country	China

Received	2023-09-24 12:23
Peer-Review Started	2023-09-24 12:25
To Make the First Decision
Return for Revision	2023-10-09 06:54
Revised	2023-10-23 12:03
Second Decision	2023-10-30 05:51
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2023-11-02 08:39
Articles in Press	2023-11-02 08:39
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2023-11-10 07:50
Publish the Manuscript Online	2023-11-16 04:01

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Case Report
Article Title	Immunotherapy in SMARCB1 (INI-1)-deficient sinonasal carcinoma: Two case reports
Manuscript Source	Unsolicited Manuscript
All Author List	Lu Zhang, Ai-Xin Gao, Yu-Lu He, Ming-Jin Xu and Hai-Jun Lu
ORCID	Author(s) ORCID Number Hai-Jun Lu http://orcid.org/0000-0003-4733-5310
Funding Agency and Grant Number
Corresponding Author	Hai-Jun Lu, PhD, Professor, Radiation Oncology, The Affiliated Hospital of Qingdao University, Haier Road , Qingdao 266000, Shandong Province, China. lhj82920608@163.com
Key Words	SMARCB1; INI-1; Sinonasal carcinoma; Gene deficient; Immunotherapy; Surgery; Case report
Core Tip	SMARCB1/INI-1 deficient sinonasal carcinoma (SDSC) is a rare carcinoma with a poor prognosis and no standard treatment guidelines. Currently, the most effective treatment option is surgery followed by adjuvant chemoradiotherapy. Here, we present two SDSC patients with complicated consultation experiences. The patients differed in treatments and prognoses, and there was no indications of local recurrence or distant metastases in patient with immunotherapy. We also review the literature on SDSC treatment. This first report on immunotherapy in SDSC provides a unique perspective on treatments for this rare tumor.
Publish Date	2023-11-16 04:01
Citation	Zhang L, Gao AX, He YL, Xu MJ, Lu HJ. Immunotherapy in SMARCB1 (INI-1)-deficient sinonasal carcinoma: Two case reports. World J Clin Cases 2023; 11(32): 7911-7919
URL	https://www.wjgnet.com/2307-8960/full/v11/i32/7911.htm
DOI	https://dx.doi.org/10.12998/wjcc.v11.i32.7911

Full Article (PDF)	WJCC-11-7911-with-cover.pdf
Full Article (Word)	WJCC-11-7911.docx
CARE Checklist–2016	88419-CARE Checklist (2016).pdf
Manuscript File	88419_Auto_Edited-LJH-JLW.docx
Answering Reviewers	88419-Answering reviewers.pdf
Audio Core Tip	88419-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	88419-Conflict-of-interest statement.pdf
Copyright License Agreement	88419-Copyright license agreement.pdf
Signed Consent for Treatment Form(s) or Document(s)	88419-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate	88419-Language certificate.pdf
Peer-review Report	88419-Peer-review(s).pdf
Scientific Misconduct Check	88419-Bing-Liu JH-2.png
Scientific Misconduct Check	88419-CrossCheck.png
Scientific Editor Work List	88419-Scientific editor work list.pdf
CrossCheck Report	88419-CrossCheck report.pdf